Source | Role | PRP | ACS | |
Platelets | Blood | Initial control of haemorrhage, release GF at injury site | 3–86–8 | N/A (serum contains no platelets) |
PDGF | Platelets | Stimulates cell replication, angiogenesis, mitogen for fibroblasts14 | 5–299 20 | No difference26 29 |
VEGF | Platelets | Angiogenesis34 | 6–52.78 9 | No data |
TGF-β1 | Platelets | Key regulator in balance between fibrosis and myocyte regeneration4 35 | 3.5–278 9 20 | 1.326 29 |
FGF | Platelets | Simulates proliferation of myoblasts, angiogenesis1 8 12 | "detected"9 | 7.526 29 |
EGF | Platelets | Proliferation of mesenchymal & epithelial cells, potentiation of other GFs36 | 38 | No data |
HGF | Plasma | Angiogenesis, mitogen for endothelial cells,21 anti-fibrotic10 | No increase from baseline22 | 1.326 |
IGF-1 | Plasma/liver | Stimulates myoblasts & fibroblasts, mediator in growth & repair of skeletal muscle35 37 | No increase from baseline8 9 22 25 | No difference26 |
EGF, epidermal growth factor; GF, growth factor; HGF, hepatocyte growth factor; IGF-1, insulin-like growth factor-1; PDGF, platelet-derived growth factor; PRP, platelet-rich plasma; TGF-β1, transforming growth factor beta-1; VEGF, vascular endothelial growth factor.